BNTX
NASDAQ
DE
BioNTech SE - American Depositary Shares
$91,18
▲ +$1,76
(+1,97%)
Vol. 787K
7
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$22.9B
ROE
-3,0%
Margine
8,5%
D/E
1,33
Beta
1,51
52W
$81–$129
Consenso Wall Street
27 analisti · Apr 20266
Acquisto forte
15
Compra
6
Mantieni
0
Vendi
0
Vendita forte
77,8%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 80,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $-0,19 | $-1,25 | $-1,06 |
| Set 2025 | $-0,22 | $-0,12 | +$0,10 |
| Giu 2025 | $-2,05 | $-1,60 | +$0,45 |
| Mar 2025 | $-2,13 | $-1,73 | +$0,40 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $1.2B | $182.8M | $260.8M | $1.5B | $907.4M |
| Utile netto | — | $259.5M | -$415.8M | -$386.6M | -$28.7M | -$305.0M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -1.8% | -1.8% | -1.8% | -1.8% | -3.0% | -3.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -24.2% | -24.2% | -24.2% | 8.5% | 8.5% |
| Gross Margin | — | 84.9% | 84.9% | 84.9% | 86.8% | 86.8% |
| D/E Ratio | 1.46 | 1.46 | 1.46 | 1.46 | 1.33 | 1.33 |
| Current Ratio | 8.61 | 8.61 | 8.61 | 8.61 | 7.12 | 7.12 |
Rapporti chiave
ROA (TTM)
-2,6%
P/S (TTM)
7,20
P/B
1,2
EPS (TTM)
$-2,36
CF/Share
$13,01
Crescita ricavi 3A
-47,5%
52W High
$129,27
52W Low
$81,20
$81,20
Intervallo 52 settimane
$129,27
Salute finanziaria
Flusso di cassa libero
$247.4M
Debito netto
-$7.4B
Liquidità
$7.7B
Debito totale
$267.4M
Aggiornato al Dic 31, 2025
Як BNTX виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка BNTX vs аналоги Biotechnology
P/E
—
▼
0%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
7,2
▼
44%
sotto
peer
(12,9)
vs Peer
vs Settore
Sottovalutato
P/B
1,2
▼
51%
sotto
peer
(2,5)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість BNTX vs аналоги Biotechnology
ROE
-3,0%
▲
95%
sopra
peer
(-67,3%)
vs Peer
vs Settore
Top livello
Net margin
8,5%
▲
103%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
86,8%
▲
10%
sopra
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
-2,6%
▲
94%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя BNTX vs аналоги Biotechnology
D/E ratio
1,3
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
In linea
Поточна ліквідність
7,1
▲
60%
sopra
peer
(4,4)
vs Peer
vs Settore
Sotto media
Beta
1,5
▲
55%
sopra
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів BNTX
BNTX
Mediana peer
Industria
BNTX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
BNTX vs аналоги: ключові метрики
Segnali Correlati
Ultima opinione AI
Grok
SKIP
Price action shows a sharp plunge to a low of $79.52 on March 9, 2026, with massive volume (21.8M shares), followed by a partial recovery to $90.86, but no clear upward momentum or higher lows yet, making this a risky …
Mar 23, 2026Principali azionisti
Top 5: 9,18%FMR, LLC
2,47%
$508.4M
T. Rowe Price Investment Ma…
1,87%
$384.2M
Flossbach von Storch SE
1,75%
$359.5M
Primecap Management Company
1,58%
$325.6M
Dodge & Cox Inc.
1,51%
$309.7M
Aggiornato al Dic 31, 2025
Dividendi
$2,11
/ anno
Giu 02, 2022
$2,1110